20 insiders reported 98 Form 4 transactions for MoonLake Immunotherapeutics (MLTX) over the past 18 months (most recent 2026-07-29). Recent activity: Reich Kristian (Chief Scientific Officer) Sell 1,100 shares, Reich Kristian (Chief Scientific Officer) Sell 50,000 shares, Reich Kristian (Chief Scientific Officer) Sell 2,448 shares, Reich Kristian (Chief Scientific Officer) Sell 43,700 shares, Reich Kristian (Chief Scientific Officer) Sell 16,105 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-29 | Reich Kristian | Chief Scientific Officer | Sell | 1,100 | $22,000 |
| 2026-07-23 | Reich Kristian | Chief Scientific Officer | Sell | 50,000 | $1.0M |
| 2026-07-23 | Reich Kristian | Chief Scientific Officer | Sell | 2,448 | $48,960 |
| 2026-07-21 | Reich Kristian | Chief Scientific Officer | Sell | 43,700 | $877,933 |
| 2026-07-20 | Reich Kristian | Chief Scientific Officer | Sell | 16,105 | $322,261 |
| 2026-07-13 | Santos da Silva Jorge | Chief Executive Officer | Sell | 68,289 | $1.4M |
| 2026-07-13 | Santos da Silva Jorge | Chief Executive Officer | Sell | 33,936 | $679,059 |
| 2026-07-02 | Santos da Silva Jorge | Chief Executive Officer | Sell | 47,775 | $956,933 |
| 2026-06-23 | Bodenstedt Matthias | Chief Financial Officer | Sell | 39,120 | $862,205 |
| 2026-06-18 | Bodenstedt Matthias | Chief Financial Officer | Sell | 15,082 | $296,814 |
| 2026-06-18 | Bodenstedt Matthias | Chief Financial Officer | Sell | 2,794 | $54,762 |
| 2026-06-17 | Reich Kristian | Chief Scientific Officer | Sell | 50,000 | $935,000 |
| 2026-06-17 | Reich Kristian | Chief Scientific Officer | Sell | 50,000 | $944,500 |
| 2026-06-17 | Reich Kristian | Chief Scientific Officer | Sell | 50,000 | $971,500 |
| 2026-05-13 | Bodenstedt Matthias | Chief Financial Officer | Sell | 13,653 | $273,333 |
| 2026-04-16 | Bodenstedt Matthias | Chief Financial Officer | Sell | 2,426 | $47,453 |
| 2026-04-14 | Santos da Silva Jorge | Chief Executive Officer | Sell | 98,127 | $1.8M |
| 2026-04-14 | Santos da Silva Jorge | Chief Executive Officer | Sell | 51,873 | $945,645 |
| 2026-04-10 | Bodenstedt Matthias | Chief Financial Officer | Sell | 85,870 | $1.6M |
| 2026-04-10 | Bodenstedt Matthias | Chief Financial Officer | Sell | 1,925 | $37,557 |
| 2026-04-02 | BVF PARTNERS L P/IL | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | LAMPERT MARK N | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | BVF INC/IL | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | Biotechnology Value Trading Fund OS LP | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | BVF Partners OS Ltd. | Director | Sell | 1.9M | $32.4M |
Source: SEC Form 4 filings · as of 2026-07-29